학술논문
Combined Blockage of E-Selectin and CXCR4 (GMI-1359) Enhances Anti-Leukemia Effect of FLT3 Inhibition (Sorafenib) and Protects Hematopoiesis in Pre-Clinical AML Models
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:17-18
Subject
Language
ISSN
0006-4971